Literature DB >> 6435862

Cellular DNA of human neoplastic B-cells measured by flow cytometry.

R C Braylan, N A Benson, V A Nourse.   

Abstract

Flow cytometric analysis of DNA of tumor cells rapidly provides information on cell kinetics and tumor ploidy. Human B-cell lymphomas, however, often contain high numbers of nonneoplastic cells, mainly T-lymphocytes, which may hamper the accurate measurement of cell cycle phases and ploidy level of these tumors. The neoplastic cells in each B-cell lymphoma express a single immunoglobulin light chain. Therefore, we labeled surface immunoglobulin light chains to discriminate between predominantly neoplastic B-cells and nonneoplastic cells in the same tissues. Using this label as well as antibodies against nonneoplastic T-cells, we performed multiparameter correlated flow cytometric analysis of 52 human B-cell lymphomas measuring cellular DNA in neoplastic and nonneoplastic populations from the same tissues without physical separation of cells. Comparison of cellular DNA of immunoglobulin light chain-bearing neoplastic cells with that of nonneoplastic cells from the same tumor enabled us to detect DNA changes (aneuploidy) in almost 80% of the lymphomas, an incidence higher than observed previously by conventional DNA analysis of unseparated cells. These ploidy changes were confirmed by comparing in the same tumor the DNA of normal T-cells with that of predominantly neoplastic cells. The proportion of neoplastic cells in the synthetic phase of the cell cycle (S-fraction) varied widely from tumor to tumor. Lymphomas with high neoplastic S-fractions (higher than 10%) were mostly hyperdiploid tumors and histologically corresponded to intermediate- and high-grade unfavorable lymphomas. Tumors with low neoplastic S-fractions (less than 5%) were predominantly diploid and near diploid, histologically low-grade lymphomas. Six lymphomas showed two discrete cell populations bearing the same immunoglobulin light chain but containing different amounts of DNA suggesting the presence of two neoplastic clones in the same tumor (biploidy). In two patients in whom the lymphoma relapsed at 17 and 34 months, respectively, after the initial biopsies, repeat tumor samples were obtained. Despite an increase in the neoplastic S-fraction, no change in ploidy level was observed in either case. Light scatter analysis suggested a relationship between cell size and genomic size; large cells in these tumors were mostly presynthetic aneuploid cells. The ability to measure DNA, antigens, and cell size in individual cells in a rapid, correlated manner is a unique attribute of flow cytometry.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6435862

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  DNA ploidy patterns and cytokinetics of non-Hodgkin's lymphoma.

Authors:  S K Juneja; I A Cooper; G S Hodgson; M M Wolf; J C Ding; P N Ironside; R J Thomas; J D Parkin
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

2.  DNA aneuploidy in Hodgkin's disease. A multiparameter flow-cytometric analysis with cytologic correlation.

Authors:  J Anastasi; K D Bauer; D Variakojis
Journal:  Am J Pathol       Date:  1987-09       Impact factor: 4.307

3.  The role of cell cycle activity in the generation of morphologic heterogeneity in non-Hodgkin's lymphoma.

Authors:  D S Weinberg
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

4.  Flow-cytometric DNA content of histiocytosis X (Langerhans cell histiocytosis).

Authors:  M S Rabkin; C T Wittwer; C R Kjeldsberg; M W Piepkorn
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

5.  DNA content of T-cell lymphomas. A flow-cytometric analysis.

Authors:  D A Egerter; J W Said; S Epling; S Lee
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

6.  Prognostic importance of DNA flow cytometry in non-Hodgkin's lymphomas.

Authors:  J C Macartney; R S Camplejohn; J Alder; M G Stone; G Powell
Journal:  J Clin Pathol       Date:  1986-05       Impact factor: 3.411

7.  Choice of fixation and denaturation for the triple labelling of intra-cytoplasmic antigen, bromodeoxyuridine and DNA. Application to bone marrow plasma cells.

Authors:  M Ffrench; F Morel; C Souchier; M Benchaib; R Catallo; P A Bryon
Journal:  Histochemistry       Date:  1994-06

8.  DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.

Authors:  R A Cowan; M Harris; M Jones; D Crowther
Journal:  Br J Cancer       Date:  1989-12       Impact factor: 7.640

9.  DNA content and prognosis of non-Hodgkin's lymphoma.

Authors:  D R Morgan; J M Williamson; P Quirke; A D Clayden; M E Smith; C J O'Brien; D L Allison; J A Child; C C Bird
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640

10.  Proliferation and apoptosis in malignant and normal cells in B-cell non-Hodgkin's lymphomas.

Authors:  T Stokke; H Holte; L Smedshammer; E B Smeland; O Kaalhus; H B Steen
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.